A Potent Glucose-Platinum Conjugate Exploits Glucose Transporters and Preferentially Accumulates in Cancer Cells

Malay Patra, Timothy C. Johnstone, Kogularamanan Suntharalingam, Stephen J. Lippard*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

138 Citations (Scopus)
195 Downloads (Pure)

Abstract

Three rationally designed glucose-platinum conjugates (Glc-Pts) were synthesized and their biological activities evaluated. The Glc-Pts, 1-3, exhibit high levels of cytotoxicity toward a panel of cancer cells. The subcellular target and cellular uptake mechanism of the Glc-Pts were elucidated. For uptake into cells, Glc-Pt 1 exploits both glucose and organic cation transporters, both widely overexpressed in cancer. Compound 1 preferentially accumulates in and annihilates cancer, compared to normal epithelial, cells in vitro. Glucose-platinum conjugates for targeted delivery: A rationally designed potent glucose-platinum conjugate exploits glucose transporters, which are widely overexpressed in cancers, for internalization and selectively accumulates in and annihilates cancer cells.

Original languageEnglish
Pages (from-to)2550-2554
Number of pages5
JournalANGEWANDTE CHEMIE-INTERNATIONAL EDITION
Volume55
Issue number7
Early online date8 Jan 2016
DOIs
Publication statusPublished - 12 Feb 2016

Keywords

  • antitumor agents
  • glucose transporters
  • glycoconjugates
  • medicinal inorganic chemistry
  • platinum

Fingerprint

Dive into the research topics of 'A Potent Glucose-Platinum Conjugate Exploits Glucose Transporters and Preferentially Accumulates in Cancer Cells'. Together they form a unique fingerprint.

Cite this